Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

By sjmartinez • June 30, 2024

Glaviano A, Wander SA, Baird RD, Yap KC, Lam HY, Toi M, Carbone D, Geoerger B, Serra V, Jones RH, Ngeow J, Toska E, Stebbing J, Crasta K, Finn RS, Diana P, Vuina K, de Bruin RAM, Surana U, Bardia A, Kumar AP. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment. Drug Resist Updat. 2024 Jun 25;76:101103. doi: 10.1016/j.drup.2024.101103. Epub ahead of print. PMID: 38943828.

Tags: CDK4/6i resistance, CDK4/CDK6 inhibitors (CDK4/6i), Cyclin-dependent kinases 4 (CDK4), cyclin-dependent kinases 6 (CDK6), endocrine therapy (ET), Hematology/Oncology, hormone receptor-positive (HR(+)) breast cancer, Publications

Effect of cross-platform gene-expression, computational methods on breast cancer subtyping in PALOMA-2 and PALLET studies

Cheang MCU, Rimawi M, Johnston S, Jacobs SA, Bliss J, Pogue-Geile K, Kilburn L, Zhu Z, Schuster EF, Xiao H, Swaim L, Deng S, Lu[...]

When Will Real-World Data Fulfill Its Promise to Provide Timely Insights in Oncology?

Berger ML, Ganz PA, Zou KH, Greenfield S. When Will Real-World Data Fulfill Its Promise to Provide Timely Insights in Oncology? JCO Clin Cancer Inform.[...]

A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data

Samorodnitsky S, Campbell K, Ribas A, C Wu M. A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data. Bioinformatics. 2024 Jul 1:btae425. doi: 10.1093/bioinformatics/btae425. Epub[...]